Hanan Elimam

948 total citations
60 papers, 709 citations indexed

About

Hanan Elimam is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Hanan Elimam has authored 60 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Cancer Research and 8 papers in Pharmacology. Recurrent topics in Hanan Elimam's work include Cancer-related molecular mechanisms research (14 papers), Circular RNAs in diseases (12 papers) and RNA modifications and cancer (7 papers). Hanan Elimam is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), Circular RNAs in diseases (12 papers) and RNA modifications and cancer (7 papers). Hanan Elimam collaborates with scholars based in Egypt, Saudi Arabia and Canada. Hanan Elimam's co-authors include Andrey V. Cybulsky, Tomoko Takano, Khalid M. El‐Say, Joan Papillon, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, Fatema R. Saber, Ahmed S. Doghish, Usama Ramadan Abdelmohsen and Ahmed M. Sayed and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Molecules.

In The Last Decade

Hanan Elimam

56 papers receiving 703 citations

Peers

Countries citing papers authored by Hanan Elimam

Since Specialization

Citations

This map shows the geographic impact of Hanan Elimam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan Elimam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan Elimam more than expected).

Fields of papers citing papers by Hanan Elimam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan Elimam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan Elimam. The network helps show where Hanan Elimam may publish in the future.

Co-authorship network of co-authors of Hanan Elimam

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan Elimam. A scholar is included among the top collaborators of Hanan Elimam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan Elimam. Hanan Elimam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Hanan Elimam, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, Hebatallah A. Darwish, (unknown), Nora M. Aborehab, Sherif S. Abdel Mageed, (unknown), Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Ahmed S. Doghish	3
2	Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches 2025 ·The Journal of Gene Medicine ·Ahmed S. Doghish, Mai A. Abd‐Elmawla, (unknown), Nora M. Aborehab, (unknown), (unknown), (unknown), Hanan Elimam	0
3	Green synthesized Gmelina arborea Roxb leaves ZnO nanoparticles: DNA fingerprinting, phytochemistry, greenness and biological activities 2025 ·Fitoterapia ·Abeer M. El Sayed, Seham S. El‐Hawary, Hanan Elimam, Mohamed A. El Raey, (unknown), (unknown), (unknown), Mohamed M. Mohyeldin	0
4	Association of Zinc Finger-76 rs10947540 polymorphism and its gene expression in Egyptian patients with systemic lupus erythematosus 2025 ·Gene ·(unknown), Hanan Elimam, Maha Ibrahim, Sarah Shabayek, Dina M. Abo‐Elmatty, Noha M. Mesbah, (unknown)	1
5	The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease 2025 ·Molecular Neurobiology ·(unknown), (unknown), Ahmed I. Abulsoud, Sherif S. Abdel Mageed, Alaa Ashraf, Elsayed G.E. Elsakka, (unknown), Mouhannad M. Sadek, (unknown), (unknown), Hanan Elimam, Ahmed Hassan Ibrahim Faraag, (unknown), Mohamed A. Ali, Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Ahmed S. Doghish	2
6	Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways 2025 ·Functional & Integrative Genomics ·Ahmed S. Doghish, (unknown), Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, (unknown), (unknown), Nora M. Aborehab, (unknown), Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Hanan Elimam	3
7	Nanoformulation of valsartan-loaded tablet attenuates L-NAME-induced hypertension: role of Nrf2/PPARγ/AT1 signaling pathway 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Hanan Elimam, Khalid M. El‐Say, Tarek A. Ahmed, Sylvie Marleau, Zakaria El-Khayat, (unknown), Jihan Hussein	1
8	Long non-coding RNAs and signaling networks in non-small cell lung cancer: mechanistic insights into tumor pathogenesis 2025 ·Cancer Gene Therapy ·Hanan Elimam, (unknown), (unknown), (unknown), Mai A. Abd‐Elmawla, Nora M. Aborehab, (unknown), (unknown), Ahmed S. Doghish	2
9	Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay 2024 ·International Journal of Biological Macromolecules ·Ahmed S. Doghish, (unknown), Mohamed Bakr Zaki, (unknown), (unknown), (unknown), (unknown), Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Hanan Elimam	12
10	Furofuranoid-Type Lignans and Related Phenolics from Anisacanthus virgularis (Salisb.) Nees with Promising Anticholinesterase and Anti-Ageing Properties: A Study Supported by Molecular Modelling 2024 ·Plants ·Mohamed A. A. Orabi, (unknown), Hanan Elimam, Yaseen A. M. M. Elshaier, (unknown), (unknown), Abdulaziz Hassan Alhasaniah, (unknown)	4
11	Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance 2024 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Hanan Elimam, (unknown), (unknown), (unknown), Abdelkader E. Ashour, (unknown), (unknown), Mohamed Bakr Zaki, Osama A. Mohammed, (unknown), Mustafa Ahmed Abdel‐Reheim, (unknown), Ahmed S. Doghish	7
12	ESI-LC-MS/MS based comparative multivariate metabolomic and biological profiling with dynamic molecular docking of Gmelina arborea Roxb different organs 2023 ·Fitoterapia ·Abeer M. El Sayed, Seham S. El‐Hawary, Hanan Elimam, Abdulrahman M. Saleh, (unknown), Mohamed M. Mohyeldin, (unknown)	6
13	The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: A review focus on signaling pathways 2023 ·Pathology - Research and Practice ·Ahmed S. Doghish, Mohamed Bakr Zaki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abdelkader E. Ashour, Hanan Elimam	10
14	Anti-androgenic potential of the fruit extracts of certain Egyptian Sabal species and their genetic variability studies: a metabolomic-molecular modeling approach 2022 ·Food & Function ·(unknown), Seham S. El‐Hawary, Mohamed A. M. Atia, Ahmed M. Sayed, Mahmoud El‐Daly, (unknown), Hanan Elimam, Usama Ramadan Abdelmohsen, Fatema R. Saber	1
15	Structural determination and anticholinesterase assay of C-glycosidic ellagitannins from Lawsonia inermis leaves: A study supported by DFT calculations and molecular docking 2022 ·Fitoterapia ·Mohamed A. A. Orabi, Esam A. Orabi, (unknown), Esam A. Orabi, Tsutomu Hatano, Hanan Elimam	3
16	Rosuvastatin lyophilized tablets loaded with flexible chitosomes for improved drug bioavailability, anti-hyperlipidemic and anti-oxidant activity 2020 ·International Journal of Pharmaceutics ·Tarek A. Ahmed, Hanan Elimam, (unknown), (unknown), (unknown), (unknown), Khalid M. El‐Say	29
17	A Linear Fragment of Unacylated Ghrelin (UAG6−13) Protects Against Myocardial Ischemia/Reperfusion Injury in Mice in a Growth Hormone Secretagogue Receptor-Independent Manner 2019 ·Frontiers in Endocrinology ·(unknown), Hanan Elimam, (unknown), (unknown), Yan Burelle, Riccarda Granata, André C. Carpentier, Huy Ong, Sylvie Marleau	8
18	Comparative Study of the Possible Prophylactic and Curative Effects of Flaxseed Oil on the Lipid Profile and Antioxidant Status of Hyperlipidaemic Rats 2018 ·Journal of Applied Pharmacy ·Hanan Elimam, (unknown)	10
19	Complement-Mediated Cellular Injury 2013 ·Seminars in Nephrology ·Tomoko Takano, Hanan Elimam, Andrey V. Cybulsky	57
20	Involvement of endogenous leukotriene B₄ and platelet‐activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats 2008 ·Immunology ·(unknown), Hanan Elimam, Julie Lefebvre, Pierre Borgeat, Sylvie Marleau	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact